These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6753665)

  • 21. The spectrum of cystic fibrosis. A study of pulmonary mechanics in 46 patients.
    Landau LI; Phelan PD
    Am Rev Respir Dis; 1973 Sep; 108(3):593-602. PubMed ID: 4745256
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lung function in mucoviscidosis: which marker is the most telling?].
    Reinhardt D
    MMW Fortschr Med; 2014 Apr; 156(6):28. PubMed ID: 24919288
    [No Abstract]   [Full Text] [Related]  

  • 23. Why did density dependence of maximal expiratory flows not become a useful epidemiological tool?
    Teculescu DB; Préfaut C
    Bull Eur Physiopathol Respir; 1987; 23(6):639-48. PubMed ID: 3331125
    [No Abstract]   [Full Text] [Related]  

  • 24. Between-technician variation in the measurement of spirometry with air and helium.
    Li KY; Tan LT; Chong P; Dosman JA
    Am Rev Respir Dis; 1981 Aug; 124(2):196-8. PubMed ID: 7258832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between airflow obstruction and coronary atherosclerosis in asymptomatic individuals: evaluation by coronary CT angiography.
    Kim JJ; Kim DB; Jang SW; Cho EJ; Chang K; Baek SH; Youn HJ; Chung WS; Seung KB; Rho TH; Jung JI; Hwang BH
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):641-648. PubMed ID: 29139033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between spirometric indices and ambulatorial clinical checking of patients with cystic fibrosis].
    Rigillo N; Manca A; Mallardi A; Corrado R
    Pediatria (Napoli); 1982 Sep; 90(3):259-67. PubMed ID: 7155700
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of MEF 25-75 as an estimate of the amount of infirmity in a presenting obstructive syndrome].
    Pivetaud J
    Rev Fr Mal Respir; 1982; 10(6):417-24. PubMed ID: 7163597
    [No Abstract]   [Full Text] [Related]  

  • 28. [Asthma and chronic obstructive bronchopneumopathy: differential diagnosis].
    Yernault JC
    Rev Med Brux; 1999 Sep; 20(4):A293-5. PubMed ID: 10523908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 30. The First Second Timed vital capacity and the course of obstructive lung diseases.
    Sobol BJ; Emirgil C
    Chest; 1977 Jul; 72(1):81-3. PubMed ID: 872660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The volume of isoflow and increase in maximal flow at 50 percent of forced vital capacity during helium-oxygen breathing as tests of small airway dysfunction.
    Gelb AF; Klein E
    Chest; 1977 Mar; 71(3):396-9. PubMed ID: 837755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung function in childhood. III. Measurement of airflow resistance in healthy children.
    Cogswell JJ; Hull D; Milner AD; Norman AP; Taylor B
    Br J Dis Chest; 1975 Jul; 69():177-87. PubMed ID: 1201185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The physiologic basis of spirometry.
    Hayes D; Kraman SS
    Respir Care; 2009 Dec; 54(12):1717-26. PubMed ID: 19961639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma of the oesophagus and obstructive airway disease.
    Cane RD; Solomon A; Hunt JA; Payne TR
    S Afr J Surg; 1979 Sep; 17(3):159-64. PubMed ID: 515858
    [No Abstract]   [Full Text] [Related]  

  • 35. FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia.
    Vilozni D; Lavie M; Sarouk I; Bar-Aluma BE; Dagan A; Ashkenazi M; Ofek M; Efrati O
    Respir Med; 2015 Jul; 109(7):890-6. PubMed ID: 26033643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an external resistance on maximum flow in chronic obstructive lung disease: implications for recognition of coincident upper airway obstruction.
    Robertson DR; Swinburn CR; Stone TN; Gibson GJ
    Thorax; 1989 Jun; 44(6):461-8. PubMed ID: 2763255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of spirometric measurements to detect airway obstruction in infants.
    Jones MH; Howard J; Davis S; Kisling J; Tepper RS
    Am J Respir Crit Care Med; 2003 May; 167(9):1283-6. PubMed ID: 12615631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forced vital capacity, airway obstruction and survival in a general population sample from the USA.
    Burney PG; Hooper R
    Thorax; 2011 Jan; 66(1):49-54. PubMed ID: 20980245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchial lability in cystic fibrosis.
    Skorecki K; Levison H; Crozier DN
    Acta Paediatr Scand; 1976 Jan; 65(1):39-44. PubMed ID: 1251723
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of maximal mid-expiratory flow, flow volume curves, and nitrogen closing volumes in patients with mild airway obstruction.
    Abboud RT; Morton JW
    Am Rev Respir Dis; 1975 Apr; 111(4):405-17. PubMed ID: 1124886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.